查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2020026

2026-2034年全球皮癬菌甲癬治療市場規模、佔有率、趨勢和成長分析報告

Global Dermatophytic Onychomycosis Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 135 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年，皮癬菌甲癬治療市場規模將達到 126.1 億美元，而 2025 年為 62.8 億美元，預計 2026 年至 2034 年的複合年成長率將達到 8.06%。

隨著灰指甲在全球的發病率不斷上升，全球灰指甲治療市場也穩定成長。灰指甲是一種常見的指甲疾病，由皮癬菌引起，可涉及手指甲和腳趾甲。人們對真菌感染疾病的認知不斷提高，以及對適當治療重要性的理解不斷加深，正在推動對有效抗真菌藥物和治療方法的需求。

推動市場成長的因素包括人口老化、糖尿病患者增加、免疫力下降。這些因素使人們更容易感染疾病真菌。此外，診斷技術的進步以及改良型外用和口服抗真菌藥物的廣泛應用，顯著改善了治療效果。

隨著製藥公司持續加大對先進治療方法研發的投入，市場預計將進一步擴張。雷射療法和聯合治療等新型治療方法因其療效顯著而備受關注。新興國家醫療保健服務的普及也將促進皮癬菌甲癬治療市場的長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球皮癬菌甲癬治療市場：依產品類型分類

  • 市場分析、洞察與預測
  • 藥片
  • 指甲油

第5章 全球皮癬菌甲癬治療市場：依給藥途徑分類

  • 市場分析、洞察與預測
  • 口服
  • 外用

第6章 全球皮癬菌甲癬治療市場：依分銷管道分類

  • 市場分析、洞察與預測
  • 醫院藥房
  • 零售藥房
  • 網路藥房

第7章 全球皮癬菌甲癬治療市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • GSK Plc
    • Bausch Health
    • Pfizer Inc
    • GALDERMA
    • Johnson & Johnson Health Care Systems Inc
    • Cipla Limited
    • KAKEN Pharmaceutical Co. Ltd
    • Sun Pharma
    • Lupin Limited
    • Dr. Reddy's Laboratories
簡介目錄
Product Code: VMR112112646

The Dermatophytic Onychomycosis Treatment Market size is expected to reach USD 12.61 Billion in 2034 from USD 6.28 Billion (2025) growing at a CAGR of 8.06% during 2026-2034.

The global dermatophytic onychomycosis treatment market is expanding steadily due to the rising prevalence of fungal nail infections worldwide. Dermatophytic onychomycosis is a common nail disorder caused by dermatophyte fungi, affecting both fingernails and toenails. Increasing awareness about fungal infections and the importance of proper treatment has led to higher demand for effective antifungal medications and therapies.

Several factors are driving market growth, including an aging population and increasing cases of diabetes and weakened immune systems. These conditions make individuals more vulnerable to fungal infections. Additionally, advancements in diagnostic techniques and the availability of improved topical and oral antifungal drugs have significantly improved treatment outcomes.

The market is expected to grow further as pharmaceutical companies continue investing in research and development of advanced therapies. New treatment options such as laser-based therapy and combination drug treatments are gaining attention for their effectiveness. Expanding healthcare access in emerging economies will also support the long-term growth of the dermatophytic onychomycosis treatment market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Tablets
  • Nail Paints

By Route of Administration

  • Oral
  • Topical

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

COMPANIES PROFILED

  • GSK plc, Bausch Health, Pfizer Inc, GALDERMA, Johnson Johnson Health Care Systems Inc, Cipla Limited, KAKEN Pharmaceutical Co Ltd, Sun Pharma, Lupin Limited, Dr Reddys Laboratories
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Tablets Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Nail Paints Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Route Of Administration
  • 5.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Distribution Channel
  • 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product Type
    • 7.2.2 By Route Of Administration
    • 7.2.3 By Distribution Channel
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product Type
    • 7.3.2 By Route Of Administration
    • 7.3.3 By Distribution Channel
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product Type
    • 7.4.2 By Route Of Administration
    • 7.4.3 By Distribution Channel
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product Type
    • 7.5.2 By Route Of Administration
    • 7.5.3 By Distribution Channel
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product Type
    • 7.6.2 By Route Of Administration
    • 7.6.3 By Distribution Channel
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 GSK Plc
    • 9.2.2 Bausch Health
    • 9.2.3 Pfizer Inc
    • 9.2.4 GALDERMA
    • 9.2.5 Johnson & Johnson Health Care Systems Inc
    • 9.2.6 Cipla Limited
    • 9.2.7 KAKEN Pharmaceutical Co. Ltd
    • 9.2.8 Sun Pharma
    • 9.2.9 Lupin Limited
    • 9.2.10 Dr. Reddy's Laboratories